PDS Biotechnology Corp Operating Lease, Weighted Average Discount Rate, Percent
PDS Biotechnology Corp (PDSB) had Operating Lease, Weighted Average Discount Rate, Percent of 9.15% as of 2020-12-31, per its 10-K filed 2021-03-18.
Discontinued › Notes › Leases
us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent · last filed 2021-03-18
- 2020-12-31: Operating Lease, Weighted Average Discount Rate, Percent 9.15%.
- 2020-09-30: Operating Lease, Weighted Average Discount Rate, Percent 9.15%.
- 2020-06-30: Operating Lease, Weighted Average Discount Rate, Percent 9.15%.
- 2019-09-30: Operating Lease, Weighted Average Discount Rate, Percent 10.15%.
| Period end | Operating Lease, Weighted Average Discount Rate, Percent |
|---|---|
| 2020-12-31 | 9.15% 10-K · filed 2021-03-18 |
| 2020-09-30 | 9.15% 10-Q · filed 2020-11-13 |
| 2020-06-30 | 9.15% 10-Q · filed 2020-08-13 |
| 2019-09-30 | 10.15% 10-Q · filed 2019-11-07 |
| 2019-06-30 | 10.15% 10-Q · filed 2019-08-01 |
| 2019-03-31 | 10.15% 10-Q · filed 2019-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |